Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy
Nephrology Jul 03, 2018
Lim CC, et al. - The epidemiology, risk factors and outcomes of cytomegalovirus (CMV) infection were ascertained among patients with glomerulonephritis (GN) who received potent immunosuppressants (IS) via performing a single-centre retrospective study of adults with biopsy-proven GN prescribed methylprednisolone (MP), cyclophosphamide (CYC) or rituximab (RTX). Observations suggested a common prevalence of CMV infection in GN patients receiving potent IS. They recommend considering surveillance and possibly anti-viral prophylaxis for high-risk patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries